Skip to main content
OpenTrials
Completed

NCT Number: NCT05181111

Continuous Monitoring of Patients in and After the Acute Admission Ward to Optimize Clinical Pathways

Hospitals aim to hospitalize patients when necessary and discharge patients when possible. However, the triage process and discharge management of patients in e.g. the Acute Admission Ward, is not a trivial task. The upcoming technology of wearable monitoring devices, whereby patients can be continuously monitored with an unobtrusive vital signs device, might help getting more insight into patients' health condition and thus help facilitate efficient and effective triaging.

Therefore, the primary objective is to assess the effects of continuous monitoring of patients in the acute admission ward (AAW) on the percentage of patients who can be discharged home. Secondary objectives are to assess the length of stay in the acute admission ward and in the in-hospital wards, as well as the effect on admission to the intensive care unit, rapid response team calls and hospital readmission. The predictive value of algorithms applied to the monitoring data combined with other parameters to detect timely deterioration and predict discharge will be assessed. Facilitators and barriers for implementing such a system will be investigated.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rijnstate Hospital

Arnhem, 6800 TA, Netherlands

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

In order for a patient to be eligible to participate in this study, the following criteria need to be met:

  • admitted to the AAW
  • Age ≥ 18 years
  • Able to speak and read Dutch
  • Willing and able to provide written informed consent

Exclusion criteria

A patient who meets any of the following criteria will be excluded from participation:

  • Not able or willing to wear a wearable sensor on the chest continuously for 14 days
  • Planned major surgery in the upcoming 30 days
  • At the time of AAW admission already known to be discharged home or admitted to the hospital
  • Any skin condition, for example prior rash, discoloration, scars, infection, injury or open wounds at the area (Left lower rib) where the sensor needs to be placed
  • Known sensitivity to medical adhesives
  • Wearing an active implantable device (e.g. ICD, pacemaker)
  • Intend to go to the sauna or go swimming in the upcoming 14 days
  • Pregnant or breastfeeding
  • Use of creams or lotions that are known to influence the skin at the area where sensor is placed (such as medical and non-medical creams or lotions)

Treatment and study plan

wearable sensor

Device

The sensor measures vital signs including heart rate and respiratory rate, posture and level of physical activity.

Other names: Philips Healthdot

Usual Care

Other

Usual Care Monitoring

Primary outcomes

  1. Percentage of patients discharged home from acute admission ward

    Time frame: up to 7 days

    Percentage of patients discharged home from acute admission ward

Secondary outcomes

  1. Length of stay in the acute admission ward

    Time frame: up to 7 days

    Length of stay in the acute admission ward

  2. Length of stay in the in-hospital wards

    Time frame: up to 31 days

    Length of stay in the in-hospital wards

  3. Percentage of Rapid Response Team calls

    Time frame: up to 31 days

    Percentage of Rapid Response Team calls

  4. Percentage of Intensive Care Unit Admissions

    Time frame: up to 31 days

    Percentage of Intensive Care Unit Admissions

  5. Percentage of unplanned readmissions to the hospitals

    Time frame: up to 31 days

    Percentage of unplanned readmissions to the hospitals

Other outcomes

  1. Deterioration

    Time frame: up to 7 days

    Deterioration will be assessed using clinical data

  2. Facilitators and Barriers for implementing continuous monitoring system (interviews)

    Time frame: up to 31 days

    Facilitators and Barriers for implementing continuous monitoring system in practice (interviews with stakeholders)

Sponsors and collaborators

Lead sponsor

Rijnstate Hospital

Other

Collaborators

  • Philips Research Eindhoven
  • University of Twente

Registry information

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Jan 6, 2022
Registry last updated
Aug 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.